A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

NCT05914116 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

862

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: DB-1311
DRUG: Lopinavir and Ritonavir Tablets
DRUG: itraconazole
DRUG: Enzalutamide
DRUG: Abiraterone

Sponsor

DualityBio Inc.

Collaborators

[object Object]